Skip to content

Clinical study for the security and validity of posterior scleral reinforcement for high myopic retinopathy

Clinical study for the security and validity of posterior scleral reinforcement for high myopic retinopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020012
Enrollment
Unknown
Registered
2018-12-11
Start date
2018-12-30
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pathologic myopia

Interventions

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged 18 years or older, diopter = -10D, visual function continued to be damaged, obvious posterior staphyloma of the sclera, fluorescein angiography or sputum green choroidal angiography showed degenerative changes in the retina and choroid.

Exclusion criteria

Exclusion criteria: 1) Non-axial myopia: such as curvature myopia, exponential myopia, and myopia caused by other syndromes such as Mafan's syndrome, Stifkler syndrome, etc., the cause of myopia is not related to the length of the axial length; 2) Simple myopia; 3) Acute or chronic inflammation or tumor in the eyeball or its surrounding tissues; 4) Suspected glaucoma or normal tension glaucoma patients; 5) serious diseases such as heart disease, leukemia, collagen disease, diabetes, nephrotic retinopathy, severe hypertension, etc.

Design outcomes

Primary

MeasureTime frame
BCVA;axial length;refraction;GCC;OCT;FFA;Electrophysiological examination;

Countries

China

Contacts

Public ContactRuihua Wei

Tianjin Medical University Eye Hospital

rwei@tmu.edu.cn+86 13920685016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026